Your browser doesn't support javascript.
loading
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients.
van Doorn, Leni; Crombag, Marie-Rose B S; Rier, Hánah N; van Vugt, Jeroen L A; van Kesteren, Charlotte; Bins, Sander; Mathijssen, Ron H J; Levin, Mark-David; Koolen, Stijn L W.
Afiliação
  • van Doorn L; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
  • Crombag MBS; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Rier HN; Department of Internal Medicine, Albert Schweitzer Hospital, 3318 AT Dordrecht, The Netherlands.
  • van Vugt JLA; Department of Surgery, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • van Kesteren C; Department of Pharmacy, Albert Schweitzer Hospital, 3318 AT Dordrecht, The Netherlands.
  • Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
  • Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, 3318 AT Dordrecht, The Netherlands.
  • Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Pharmaceuticals (Basel) ; 14(1)2021 Jan 09.
Article em En | MEDLINE | ID: mdl-33435449
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article